ArticleHeadache2025

The influence of renal impairment on the pharmacokinetics of rimegepant: Results of a phase 1, open-label, single-dose, parallel-group study.

Rajinder Bhardwaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.